Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1241 |
|
| Actual shortage: | 53 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1152 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
208 (14%) |
|
Overdue reports |
8 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRAXIS ASA EC 81 MG DAILY LOW DOSE | 81MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-11-28 | 2019-03-29 | 67844 |
| PMS-METFORMIN | 850MG | TABLET | Resolved | 2017-09-19 | 2017-12-08 | 22789 |
| PMS-METFORMIN | 850MG | TABLET | Resolved | 2017-10-12 | 2018-02-22 | 25796 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-ENALAPRIL | 8MG | TABLET | Resolved | 2017-03-13 | 2020-04-02 | 1860 |
| PMS-ENALAPRIL | 8MG | TABLET | Resolved | 2017-03-13 | 2020-04-02 | 1869 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-04-07 | 2018-02-17 | 6129 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-06-23 | 2018-02-17 | 13703 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2017-10-12 | 2018-04-19 | 25743 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-02-12 | 2018-03-07 | 39510 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-04-20 | 2018-07-13 | 46689 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63047 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63054 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-04 | 2021-10-15 | 77459 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-28 | 2021-10-15 | 79789 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-29 | 2019-06-11 | 79847 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147331 |
| PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147335 |
| PMS-HYDROMORPHONE TAB 8MG | 8MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149376 |